Literature DB >> 30139701

A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failure.

Toshiyuki Nishikido1, Jun-Ichi Oyama2, Daisuke Nagatomo1, Koichi Node1.   

Abstract

BACKGROUND: Low body mass index (BMI) has been associated with decreased survival in patients with heart failure (HF), although Obesity is an important risk factor for cardiovascular disease. HF patients with a relatively higher BMI tend to live longer, which is known as "Obesity Paradox". However, cardiac cachexia is another determinant of prognosis in HF patients. This study investigated whether a change in BMI is associated with either prognosis or frequency of hospitalizations in patients with HF.
METHODS: We correlated changes in BMI to prognosis and frequency of hospitalizations in patients who were hospitalized for decompensated HF. A total of 971 HF patients were initially evaluated, and 81 patients with repeat HF admissions were included.
RESULTS: The average change in BMI was -0.05 ± 0.15, -0.87 ± 0.56, -1.03 ± 0.34, and -1.97 ± 0.33 in patients who were hospitalized twice, three times, four times, and over five times, respectively. The reduction in BMI correlated with the frequency of hospitalizations (P < 0.01). We compared patients with increased BMI (group I, n = 38) versus decreased BMI (group D, n = 43) between the first and second discharge. The rate of hospitalization in group D was higher than in group I, and group D had a lower survival rate. The reduction of BMI was a significant and independent risk factor for cardiac death (HR, 4.17; 95% CI, 1.53 to 14.6).
CONCLUSIONS: Losing body weight in HF patients was a significant predictive factor of the frequency of hospitalizations and increased mortality.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Body mass index; Heart failure; Hospitalization

Mesh:

Year:  2018        PMID: 30139701     DOI: 10.1016/j.ijcard.2018.08.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Body mass loss is a surrogate marker of frailty in heart failure.

Authors:  Hai M Tang; Loren Moon; Jun Yoshioka
Journal:  Int J Cardiol       Date:  2018-10-15       Impact factor: 4.164

2.  Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study.

Authors:  Kenta Kamisaka; Kuniyasu Kamiya; Kotaro Iwatsu; Naoki Iritani; Shota Imoto; Takuji Adachi; Yuki Iida; Sumio Yamada
Journal:  ESC Heart Fail       Date:  2021-10-02

Review 3.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

4.  High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox.

Authors:  Katsuhiko Ohori; Toshiyuki Yano; Satoshi Katano; Hidemichi Kouzu; Suguru Honma; Kanako Shimomura; Takuya Inoue; Yuhei Takamura; Ryohei Nagaoka; Masayuki Koyama; Nobutaka Nagano; Takefumi Fujito; Ryo Nishikawa; Tomoyuki Ishigo; Ayako Watanabe; Akiyoshi Hashimoto; Tetsuji Miura
Journal:  BMC Geriatr       Date:  2021-01-06       Impact factor: 4.070

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.